Type III Interferons: Emerging Roles in Autoimmunity
Type III interferons (IFNs) or the lambda IFNs (IFNLs or IFN-λs) are antimicrobial cytokines that play key roles in immune host defense at endothelial and epithelial barriers. IFNLs signal via their heterodimeric receptor, comprised of two subunits, IFNLR1 and interleukin (IL)10Rβ, which defines the...
Guardado en:
Autores principales: | , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/30974b42fe614b708565ecd69cff0406 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:30974b42fe614b708565ecd69cff0406 |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:30974b42fe614b708565ecd69cff04062021-12-01T04:24:05ZType III Interferons: Emerging Roles in Autoimmunity1664-322410.3389/fimmu.2021.764062https://doaj.org/article/30974b42fe614b708565ecd69cff04062021-11-01T00:00:00Zhttps://www.frontiersin.org/articles/10.3389/fimmu.2021.764062/fullhttps://doaj.org/toc/1664-3224Type III interferons (IFNs) or the lambda IFNs (IFNLs or IFN-λs) are antimicrobial cytokines that play key roles in immune host defense at endothelial and epithelial barriers. IFNLs signal via their heterodimeric receptor, comprised of two subunits, IFNLR1 and interleukin (IL)10Rβ, which defines the cellular specificity of the responses to the cytokines. Recent studies show that IFNL signaling regulates CD4+ T cell differentiation, favoring Th1 cells, which has led to the identification of IFNL as a putative therapeutic target for autoimmune diseases. Here, we summarize the IFNL signaling pathways during antimicrobial immunity, IFNL-mediated immunomodulation of both innate and adaptive immune cells, and induction of autoimmunity.Sindhu ManivasagamSindhu ManivasagamRobyn S. KleinRobyn S. KleinRobyn S. KleinRobyn S. KleinFrontiers Media S.A.articleinterferon lambdaautoimmune diseasesTh1 cellsIFNLRneuroimmunology and neuropathologyImmunologic diseases. AllergyRC581-607ENFrontiers in Immunology, Vol 12 (2021) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
interferon lambda autoimmune diseases Th1 cells IFNLR neuroimmunology and neuropathology Immunologic diseases. Allergy RC581-607 |
spellingShingle |
interferon lambda autoimmune diseases Th1 cells IFNLR neuroimmunology and neuropathology Immunologic diseases. Allergy RC581-607 Sindhu Manivasagam Sindhu Manivasagam Robyn S. Klein Robyn S. Klein Robyn S. Klein Robyn S. Klein Type III Interferons: Emerging Roles in Autoimmunity |
description |
Type III interferons (IFNs) or the lambda IFNs (IFNLs or IFN-λs) are antimicrobial cytokines that play key roles in immune host defense at endothelial and epithelial barriers. IFNLs signal via their heterodimeric receptor, comprised of two subunits, IFNLR1 and interleukin (IL)10Rβ, which defines the cellular specificity of the responses to the cytokines. Recent studies show that IFNL signaling regulates CD4+ T cell differentiation, favoring Th1 cells, which has led to the identification of IFNL as a putative therapeutic target for autoimmune diseases. Here, we summarize the IFNL signaling pathways during antimicrobial immunity, IFNL-mediated immunomodulation of both innate and adaptive immune cells, and induction of autoimmunity. |
format |
article |
author |
Sindhu Manivasagam Sindhu Manivasagam Robyn S. Klein Robyn S. Klein Robyn S. Klein Robyn S. Klein |
author_facet |
Sindhu Manivasagam Sindhu Manivasagam Robyn S. Klein Robyn S. Klein Robyn S. Klein Robyn S. Klein |
author_sort |
Sindhu Manivasagam |
title |
Type III Interferons: Emerging Roles in Autoimmunity |
title_short |
Type III Interferons: Emerging Roles in Autoimmunity |
title_full |
Type III Interferons: Emerging Roles in Autoimmunity |
title_fullStr |
Type III Interferons: Emerging Roles in Autoimmunity |
title_full_unstemmed |
Type III Interferons: Emerging Roles in Autoimmunity |
title_sort |
type iii interferons: emerging roles in autoimmunity |
publisher |
Frontiers Media S.A. |
publishDate |
2021 |
url |
https://doaj.org/article/30974b42fe614b708565ecd69cff0406 |
work_keys_str_mv |
AT sindhumanivasagam typeiiiinterferonsemergingrolesinautoimmunity AT sindhumanivasagam typeiiiinterferonsemergingrolesinautoimmunity AT robynsklein typeiiiinterferonsemergingrolesinautoimmunity AT robynsklein typeiiiinterferonsemergingrolesinautoimmunity AT robynsklein typeiiiinterferonsemergingrolesinautoimmunity AT robynsklein typeiiiinterferonsemergingrolesinautoimmunity |
_version_ |
1718405894455164928 |